EGFR and renal carcinoma: For example, although the mechanism of action by which EGFR is activated in ELSTs from patients with VHL remains to be determined, loss of VHL increases levels of the EGFR ligand, TGF-α [21], and activates EGFR in renal cancer cells [24].